FDA Grants Orphan Drug, Fast Track Designations to CV-01 in Recurrent Glioblastoma OncLive, 13 Jul 2022 CV-01, Alpheus Medical’s novel sonodynamic therapy delivery platform, has received orphan drug and fast track designations from…